A comparison study of cognitive deficits in radiologically and clinically isolated syndromes. [artículo}
Por: Labiano Fontcuberta, Andrés [Neurología]
| Benito León, Julián [Neurología] | Puertas Martín, Verónica [Neurología].
Colaborador(es): Servicio de Neurología-Neurofisiología.
Tipo de material: 
ArtículoEditor: Multiple sclerosis : clinical and laboratory research, 2016Descripción: 22(2):250-3.Recursos en línea: Solicitar documento Resumen: Up until now, no information has existed regarding a comparison of the pattern and frequency of cognitive deficits between radiologically isolated syndrome (RIS) and clinically isolated syndrome (CIS) patients. Within this objective, Rao's Brief Repeatable Battery and Stroop test were administered to 28 RIS patients, 25 CIS patients, and 22 healthy controls.
Conclusions: The prevalence of cognitive deficits in RIS was similar to that of CIS. Cognitive deficits seem to be present in RIS patients regardless of the presence of risk factors for a future symptomatic demyelinating event.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC16724 (Navegar estantería) | Disponible |
Navegando Hospital Universitario 12 de Octubre Estantes Cerrar el navegador de estanterías
Formato Vancouver:
Labiano Fontcuberta A, Martínez Ginés ML, Aladro Y, Ayuso L, Mitchell AJ, Puertas Martín V et al. A comparison study of cognitive deficits in radiologically and clinically isolated syndromes. Mult Scler. 2016 Feb;22(2):250-3.
PMID: 26084350
Contiene 10 referencias
Up until now, no information has existed regarding a comparison of the pattern and frequency of cognitive deficits between radiologically isolated syndrome (RIS) and clinically isolated syndrome (CIS) patients. Within this objective, Rao's Brief Repeatable Battery and Stroop test were administered to 28 RIS patients, 25 CIS patients, and 22 healthy controls.
Conclusions: The prevalence of cognitive deficits in RIS was similar to that of CIS. Cognitive deficits seem to be present in RIS patients regardless of the presence of risk factors for a future symptomatic demyelinating event.
No hay comentarios para este ejemplar.